We are live on ! Find out more
OWD

Osborn Williams & Donohoe Portfolio holdings

AUM $762M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
-2.74%
3 Year Est. Return
+23.69%
5 Year Est. Return
+43.75%
10 Year Est. Return
AUM
$1B
AUM Growth
+$7.18M
Cap. Flow
-$69.8M
Cap. Flow %
-6.98%
Top 10 Hldgs %
22.66%
Holding
320
New
18
Increased
64
Reduced
177
Closed
18

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$7.51M
2
TGT icon
Target
TGT
+$3.7M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.17M
4
BALL icon
Ball Corp
BALL
+$835K
5
RWT
Redwood Trust
RWT
+$832K

Sector Composition

Rank Sector Weight
1 Financials 16.37%
2 Technology 16.27%
3 Healthcare 16.13%
4 Consumer Staples 10.21%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
76
DELISTED
Activision Blizzard
ATVI
$3.64M 0.36%
61,295
+301
+0.5% +$16.7K
AVGO icon
77
Broadcom
AVGO
$1.85T
$3.63M 0.36%
114,710
+11,870
+12% +$360K
CMI icon
78
Cummins
CMI
$87.5B
$3.59M 0.36%
20,071
-255
-1% -$44.9K
FITB
79
Fifth Third Bancorp
FITB
$51.2B
$3.59M 0.36%
116,824
-19,249
-14% -$564K
DFS
80
DELISTED
Discover Financial Services
DFS
$3.58M 0.36%
42,198
+3,624
+9% +$299K
TMO icon
81
Thermo Fisher Scientific
TMO
$213B
$3.54M 0.35%
10,895
-2,813
-21% -$853K
MRK icon
82
Merck
MRK
$322B
$3.5M 0.35%
40,364
-655
-2% -$53.8K
LIN icon
83
Linde
LIN
$221B
$3.39M 0.34%
15,912
-735
-4% -$148K
RTN
84
DELISTED
Raytheon Company
RTN
$3.31M 0.33%
15,085
-41
-0.3% -$8.67K
IYJ icon
85
iShares US Industrials ETF
IYJ
$1.98B
$3.29M 0.33%
39,230
-17,904
-31% -$1.46M
IWM icon
86
iShares Russell 2000 ETF
IWM
$79.8B
$3.18M 0.32%
19,198
-4,976
-21% -$786K
AXP icon
87
American Express
AXP
$227B
$3.17M 0.32%
25,421
-6,226
-20% -$744K
MMM icon
88
3M
MMM
$90.9B
$3.13M 0.31%
21,237
-2,165
-9% -$303K
KR icon
89
Kroger
KR
$35.4B
$3.06M 0.31%
105,625
-15,121
-13% -$401K
EFA icon
90
iShares MSCI EAFE ETF
EFA
$78B
$2.93M 0.29%
42,137
-12,291
-23% -$830K
IBB icon
91
iShares Biotechnology ETF
IBB
$9.34B
$2.86M 0.29%
23,726
-7,440
-24% -$830K
IYC icon
92
iShares US Consumer Discretionary ETF
IYC
$1.17B
$2.79M 0.28%
48,824
-37,472
-43% -$2.08M
ADBE icon
93
Adobe
ADBE
$99.5B
$2.78M 0.28%
8,420
+661
+9% +$194K
CURO
94
DELISTED
CURO Group Holdings Corp.
CURO
$2.72M 0.27%
223,336
+18,445
+9% +$247K
AMP icon
95
Ameriprise Financial
AMP
$48.3B
$2.7M 0.27%
16,215
+622
+4% +$96.4K
CCI icon
96
Crown Castle
CCI
$33.3B
$2.64M 0.26%
18,565
-30
-0.2% -$4.09K
CRM icon
97
Salesforce
CRM
$151B
$2.63M 0.26%
16,195
+1,945
+14% +$305K
DEO icon
98
Diageo
DEO
$49B
$2.62M 0.26%
15,526
+395
+3% +$64.2K
QCOM icon
99
Qualcomm
QCOM
$155B
$2.55M 0.26%
28,939
-5,270
-15% -$441K
ITW icon
100
Illinois Tool Works
ITW
$82.6B
$2.55M 0.26%
14,194
-396
-3% -$67.1K

Similar funds

Osborn Williams & Donohoe's Q4 2019 Portfolio in Review

As of Q4 2019, Osborn Williams & Donohoe held 320 positions worth $1B, up 0.72% from $993M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Osborn Williams & Donohoe withdrew a net $69.8M in Q4 2019, closing 18 positions and reducing 177 holdings. Its most notable exit was Celgene Corp, an estimated $3.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Osborn Williams & Donohoe opened a new position in Accenture worth $8.11M.

  • Osborn Williams & Donohoe's largest Q4 2019 buy was Accenture: 38,523 shares worth $8.11M.
  • Osborn Williams & Donohoe added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.17M increase.
  • Osborn Williams & Donohoe's biggest Q4 2019 reduction was Cincinnati Financial, cutting an estimated $8.78M.
  • Osborn Williams & Donohoe fully exited Celgene Corp in Q4 2019, selling an estimated $3.9M.
  • Osborn Williams & Donohoe's ten largest holdings make up 23% of its $1B portfolio in Q4 2019.
  • Osborn Williams & Donohoe opened 18 new positions and closed 18 in Q4 2019.
  • Osborn Williams & Donohoe's portfolio value rose 0.72% quarter-over-quarter to $1B.

Based on Osborn Williams & Donohoe's 13F filing for Q4 2019, filed 2 Mar 2020.